Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The main objectives of this study are: 1. To asses the safety and the tolerability of 1 cycle of APO866, administered by continuous intravenous infusion, in patients with refractory B-cell chronic lymphocytic leukemia (B-CLL) non amenable to allogeneic hematopoietic stem cell transplantation (hASCT). 2. To evaluate the effect of APO866 on leukemic B-cells in this population of patients.
Critère d'inclusion
- The medical condition for this clinical trial is B. cell chronic lymphocytic leukemia